Disseminated histoplasmosis in AIDS patients in Maryland.
These patients demonstrate the difficulty in arriving at the diagnosis of disseminated histoplasmosis. The diagnosis in two of the three patients also served as the initial AIDS case-defining opportunistic infection. In each of these patients, the clinical presentations were atypical and in only one patient was a positive exposure history elicited. Recurrent bowel obstruction was the presenting complaint in the first patient and the diagnosis was made only on pathologic exam of the resected small bowel. The second patient's diagnosis was made on biopsy of the colon via colonoscopy. The third patient's diagnosis also eluded an extensive FUO workup; he was diagnosed by bone marrow culture and silver stain of a mediastinal lymph node biopsy, despite serial negative serologic tests for histoplasmosis. The first two patients had significant gastrointestinal disease which is a relatively unusual manifestation for disseminated histoplasmosis. The third patient illustrates the limited diagnostic usefulness of serologic testing in AIDS patients and the continued usefulness of bone marrow analysis in an FUO evaluation. In conclusion, these case presentations demonstrate that disseminated histoplasmosis in patients with HIV infection can present with unusual manifestations, outside of the typical endemic arca, without a positive exposure history or positive serologic test, and may be the initial AIDS case-defining opportunistic infection in these patients. Consequently, a disseminated histoplasmosis should be considered in all AIDS patients with perplexing clinical presentations.
Sauri
M A
MA
Montgomery General Hospital, Maryland.
Julie
N L
NL
Juarbe
H M
HM
Mayo
F J
FJ
Ligon
C H
CH
Fox
R L
RL
Koss
G
G
Coggin
J T
JT
Burbach
J W
JW
Barton
J H
JH
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000328:Adult; D000368:Aged; D000666:Amphotericin B / Q000627:therapeutic use; D005260:Female; D006658:Histoplasma / Q000032:analysis; D006660:Histoplasmosis / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D007654:Ketoconazole / Q000627:therapeutic use; D008297:Male; D008396:Maryland; D008875:Middle Aged; D009894:Opportunistic Infections / Q000150:complications* / Q000188:drug therapy
D000666:Amphotericin B; D007654:Ketoconazole